Cyberonics Treatment IDE To Allow For Limited Use Of VNS For Depression

Cyberonics' strategy of obtaining a treatment IDE for its vagus nerve stimulation VNS Therapy for depression will place the device in the hands of more physicians, but will not necessarily help reverse FDA's non-approvable decision

More from Archive

More from Medtech Insight